Sathish Muthu

Dr. Sathish Muthu

Sharda University, Greater Noida, Uttar Pradesh, India.
+1
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 June 2023 in Nature Reviews Rheumatology
Verified
Journal Article
Closed access
PDF file
Sathish MuthuSathish Muthu
Sathish Muthu
JKJasmijn V. Korpershoek
Jasmijn V. Korpershoek
ENEmanuel J. Novais
Emanuel J. Novais
GTGwenllian F. Tawy
Gwenllian F. Tawy
AHAnthony P. Hollander
Anthony P. Hollander
IMIvan Martin
Ivan Martin

1 April 2021 in Stem Cell Investigation
Verified
Journal Article
Open access
PDF file
Sathish MuthuSathish Muthu
Sathish Muthu
ABAsawari Bapat
Asawari Bapat
RJRashmi Jain
Rashmi Jain
NJNaveen Jeyaraman
Naveen Jeyaraman
Madhan JeyaramanMadhan Jeyaraman
Madhan Jeyaraman
The recent advances in translational and nanomedicine have paved the way for developing the targeted drug delivery system at a greater pace among global researchers. On par with these technologies, exosomes act as a potential portal for cell-free drug delivery systems as these are bestowed with the native characteristics of the parent cell of origin. Exosomes, called extracellular vesicles (EcVs), are present in almost all cells, tissues, and body fluids. They help in intercellular signaling and maintains tissue homeostasis in the disease pathobiology. Researchers have characterized 9,769 proteins, 2,838 miRNAs, 3,408 mRNAs, and 1,116 lipids being present in exosomal cargo. The separation of exosomes from cells, tissues, and body fluids follow different patterned kinetics. Exosomes interact with the recipient cells through their surface receptor molecules and ligands and internalize within recipient cells through micropinocytosis and phagocytosis. Advancing technologies in regenerative medicine have facilitated the researchers to isolate exosomes from mesenchymal stem cells (MSCs) as these cells are blessed with supreme regenerative potentiality in targeting a disease. Exosomal cargo is a key player in establishing the diagnosis and executing therapeutic role whilst regulating a disease process. Various in vitro studies have exhibited the safety, efficacy, and therapeutic potentiality of exosomes in various cancers, neurodegenerative, cardiovascular, and orthopedic diseases. This article throws light on the composition, therapeutic role, and regulatory potentials of exosomes with the widening of the horizon in the field of regenerative medicine.

19 January 2021 in Journal of Molecular Neuroscience
Verified
Journal Article
Closed access
PDF file
Niraj Kumar JhaNiraj Kumar Jha
Niraj Kumar Jha
Shreesh  OjhaShreesh Ojha
Shreesh Ojha
SJSaurabh Kumar Jha
Saurabh Kumar Jha
HDHarish Dureja
Harish Dureja
SSSachin Kumar Singh
Sachin Kumar Singh
KDKamal Dua
Kamal Dua

16 September 2020 in Global Spine Journal
Verified
Journal Article
Open access
PDF file
Sathish MuthuSathish Muthu
Sathish Muthu
EREswar Ramakrishnan
Eswar Ramakrishnan
GCGirinivasan Chellamuthu
Girinivasan Chellamuthu
Systematic review and meta-analysis. We performed this meta-analysis to evaluate whether endoscopic discectomy (ED) shows superiority compared with the current gold standard of microdiscectomy (MD) in management of lumbar disc disease. We conducted independent and duplicate electronic database search including PubMed, Embase, and Cochrane Library from 1990 till April 2020 for studies comparing ED and MD in the management of lumbar disc disease. Analysis was performed in R platform using OpenMeta[Analyst] software. We included 27 studies, including 11 randomized controlled trials (RCTs), 7 nonrandomized prospective, and 9 retrospective studies involving 4018 patients in the meta-analysis. We stratified the results based on the study design. Considering the heterogeneity in some results between study designs, we weighed our conclusion essentially based on results of RCTs. On analyzing the RCTs, superiority was established at 95% confidence interval for ED compared with MD in terms of functional outcomes like Oswestry Disability Index (ODI) score (P = .008), duration of surgery (P = .023), and length of hospital stay (P < .001) although significant heterogeneity was noted. Similarly, noninferiority to MD was established by ED in other outcomes like visual analogue scale score for back pain (P = .860) and leg pain (P = .495), MacNab classification (P = .097), recurrences (P = .993), reoperations (P = .740), and return-to-work period (P = .748). Our meta-analysis established the superiority of endoscopic discectomy in outcome measures like ODI score, duration of surgery, overall complications, length of hospital stay and noninferiority in other measures analyzed. With recent advances in the field of ED, the procedure has the potential to take over the place of MD as the gold standard of care in management of lumbar disc disease.

25 August 2020 in CARTILAGE
Verified
Journal Article
Closed access
PDF file
Madhan JeyaramanMadhan Jeyaraman
Madhan Jeyaraman
Sathish MuthuSathish Muthu
Sathish Muthu
PGParvez Ahmad Ganie
Parvez Ahmad Ganie
Meta-analysis. To compare the efficacy and safety of bone marrow(BM)–derived mesenchymal stem cell(MSCs) and adipose-derived(AD) MSCs in the management of osteoarthritis of knee from randomized controlled trials(RCTs) available in the literature. We conducted electronic database searche from PubMed, Embase, and Cochrane Library till May 2020 for RCTs analyzing the efficacy and safety of MSCs in management of osteoarthritis of knee. Visual Analog Score(VAS) for Pain, Western Ontario McMaster Universities Osteoarthritis Index(WOMAC), Lysholm Knee Scale(Lysholm), Whole-Organ Magnetic Resonance Imaging Score(WORMS), Knee Osteoarthritis Outcome Score(KOOS), and adverse events were the outcomes analyzed. Analysis was performed in R platform using OpenMeta[Analyst] software. Nineteen studies involving 811 patients were included for analysis. None of the studies compared the source of MSCs for osteoarthritis of knee and results were obtained by pooled data analysis of both sources. At 6 months, AD-MSCs showed significantly better VAS(P<0.001,P=0.069) and WOMAC(P=0.134,P=0.441) improvement than BM-MSCs, respectively, compared to controls. At 1 year, AD-MSCs outperformed BM-MSCs compared to their control in measures like WOMAC(P=0.007,P=0.150), KOOS(P<0.001;P=0.658), and WORMS(P<0.001,P=0.041), respectively. Similarly at 24 months, AD-MSCs showed significantly better Lysholm score(P=0.037) than BM-MSCs(P=0.807) although VAS improvement was better with BM-MSCs at 24 months(P<0.001). There were no significant adverse events with either of the MSCs compared to their controls. Our analysis establishes the efficacy, safety, and superiority of AD-MSC transplantation, compared to BM-MSC, in the management of osteoarthritis of knee from available literature. Further RCTs are needed to evaluate them together with standardized doses.

Verified
Journal Article
Open access
PDF file
LRLuciano C. Ramires
Luciano C. Ramires
Gabriel SantosGabriel Santos
Gabriel Santos
RRRafaela Pereira Ramires
Rafaela Pereira Ramires
LFLucas Furtado da Fonseca
Lucas Furtado da Fonseca
Madhan JeyaramanMadhan Jeyaraman
Madhan Jeyaraman
JLJosé Fábio Santos Duarte Lana
José Fábio Santos Duarte Lana
Some say that all diseases begin in the gut. Interestingly, this concept is actually quite old, since it is attributed to the Ancient Greek physician Hippocrates, who proposed the hypothesis nearly 2500 years ago. The continuous breakthroughs in modern medicine have transformed our classic understanding of the gastrointestinal tract (GIT) and human health. Although the gut microbiota (GMB) has proven to be a core component of human health under standard metabolic conditions, there is now also a strong link connecting the composition and function of the GMB to the development of numerous diseases, especially the ones of musculoskeletal nature. The symbiotic microbes that reside in the gastrointestinal tract are very sensitive to biochemical stimuli and may respond in many different ways depending on the nature of these biological signals. Certain variables such as nutrition and physical modulation can either enhance or disrupt the equilibrium between the various species of gut microbes. In fact, fat-rich diets can cause dysbiosis, which decreases the number of protective bacteria and compromises the integrity of the epithelial barrier in the GIT. Overgrowth of pathogenic microbes then release higher quantities of toxic metabolites into the circulatory system, especially the pro-inflammatory cytokines detected in osteoarthritis (OA), thereby promoting inflammation and the initiation of many disease processes throughout the body. Although many studies link OA with GMB perturbations, further research is still needed.